JPWO2020120978A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020120978A5 JPWO2020120978A5 JP2021534203A JP2021534203A JPWO2020120978A5 JP WO2020120978 A5 JPWO2020120978 A5 JP WO2020120978A5 JP 2021534203 A JP2021534203 A JP 2021534203A JP 2021534203 A JP2021534203 A JP 2021534203A JP WO2020120978 A5 JPWO2020120978 A5 JP WO2020120978A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- referred
- peptide ligand
- cysteine residues
- amino acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1820316.6A GB201820316D0 (en) | 2018-12-13 | 2018-12-13 | Bicyclic peptide ligands specific for IL-17 |
| GB1820316.6 | 2018-12-13 | ||
| PCT/GB2019/053534 WO2020120978A1 (en) | 2018-12-13 | 2019-12-13 | Bicyclic peptide ligands specific for il-17 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022515720A JP2022515720A (ja) | 2022-02-22 |
| JP2022515720A5 JP2022515720A5 (https=) | 2022-12-19 |
| JPWO2020120978A5 true JPWO2020120978A5 (https=) | 2022-12-19 |
Family
ID=65146974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021534203A Pending JP2022515720A (ja) | 2018-12-13 | 2019-12-13 | Ｉｌ－１７に特異的な二環式ペプチドリガンド |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220024983A1 (https=) |
| EP (1) | EP3894007A1 (https=) |
| JP (1) | JP2022515720A (https=) |
| CN (1) | CN113474046A (https=) |
| GB (1) | GB201820316D0 (https=) |
| WO (1) | WO2020120978A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021010453A2 (pt) | 2018-12-19 | 2021-08-24 | Leo Pharma A/S | Composto, e, composição farmacêutica |
| WO2021123767A1 (en) * | 2019-12-16 | 2021-06-24 | Bicycletx Limited | Bicyclic peptide ligands specific for il-17 |
| GB201918558D0 (en) * | 2019-12-16 | 2020-01-29 | Bicycle Tx Ltd | Bicyclic peptide ligands specific for IL-17 |
| GB201918559D0 (en) * | 2019-12-16 | 2020-01-29 | Bicycle Tx Ltd | Bicyclic peptide ligands specific for IL-17 |
| GB201918557D0 (en) * | 2019-12-16 | 2020-01-29 | Bicycle Tx Ltd | Bicyclic peptide ligands specific for IL-17 |
| KR20230019507A (ko) | 2020-04-30 | 2023-02-08 | 얀센 파마슈티카 엔.브이. | Il-17의 조절제로서의 이미다조피리다진 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1452868A2 (en) | 2003-02-27 | 2004-09-01 | Pepscan Systems B.V. | Method for selecting a candidate drug compound |
| DK1844337T3 (da) | 2005-01-24 | 2013-09-30 | Pepscan Systems Bv | Bindingsforbindelser, immunogene forbindelser og peptidmimetika |
| CN101326195B9 (zh) | 2005-12-13 | 2022-11-11 | 伊莱利利公司 | 抗il-17抗体 |
| AU2009211253B2 (en) | 2008-02-05 | 2014-11-06 | Bicyclerd Limited | Methods and compositions |
| WO2010062858A1 (en) | 2008-11-26 | 2010-06-03 | Allergan, Inc. | Il-17 antibody inhibitor for treating dry eye |
| EP2569335B1 (en) | 2010-05-14 | 2018-08-22 | Orega Biotech | Methods of treating and/or preventing cell proliferation disorders with il-17 antagonists |
| US20130195868A1 (en) | 2010-06-24 | 2013-08-01 | Eleven Biotherapeutics, Inc. | Treating surface of the eye disorders |
| JP6882978B2 (ja) | 2014-10-29 | 2021-06-02 | バイスクルアールディー・リミテッド | Ｍｔ１−ｍｍｐに特異的な二環性ペプチドリガンド |
| EP3181146A1 (en) * | 2015-12-16 | 2017-06-21 | Ruprecht-Karls-Universität Heidelberg | Cyclic ntcp-targeting peptides and their uses as entry inhibitors |
| GB201600911D0 (en) * | 2016-01-18 | 2016-03-02 | Bicycle Therapeutics Ltd | Stabilized peptide derivatives |
| GB201810327D0 (en) * | 2018-06-22 | 2018-08-08 | Bicycletx Ltd | Peptide ligands for binding to IL-17 |
-
2018
- 2018-12-13 GB GBGB1820316.6A patent/GB201820316D0/en not_active Ceased
-
2019
- 2019-12-13 JP JP2021534203A patent/JP2022515720A/ja active Pending
- 2019-12-13 WO PCT/GB2019/053534 patent/WO2020120978A1/en not_active Ceased
- 2019-12-13 EP EP19824377.6A patent/EP3894007A1/en not_active Withdrawn
- 2019-12-13 US US17/309,627 patent/US20220024983A1/en not_active Abandoned
- 2019-12-13 CN CN201980081501.8A patent/CN113474046A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020343328B2 (en) | Conjugated hepcidin mimetics | |
| JPWO2021019243A5 (https=) | ||
| JP6525471B2 (ja) | ヘプシジン類似体及びその使用 | |
| JP2025122030A5 (https=) | ||
| JPWO2020120980A5 (https=) | ||
| JP2025011099A5 (https=) | ||
| JPWO2021019244A5 (https=) | ||
| JPWO2020148525A5 (https=) | ||
| JPWO2020148526A5 (https=) | ||
| FI3746467T3 (fi) | Muutetut lipidoidut relaksiinin b-ketjun peptidit ja niiden terapeuttinen käyttö | |
| JP2006514104A5 (https=) | ||
| JPWO2020120981A5 (https=) | ||
| JPWO2020128527A5 (https=) | ||
| JP6633523B2 (ja) | Ｐｓｄ−９５の二量体阻害剤脂肪酸誘導体 | |
| JP2007534698A5 (https=) | ||
| JPWO2021019245A5 (https=) | ||
| JPWO2020120983A5 (https=) | ||
| JPWO2020148529A5 (https=) | ||
| JPWO2020128526A5 (https=) | ||
| JPWO2020148530A5 (https=) | ||
| JPWO2021074622A5 (https=) | ||
| JP2023526067A (ja) | 抗感染性二環式ペプチドリガンド | |
| JPWO2020148528A5 (https=) | ||
| JPWO2020120978A5 (https=) | ||
| JP2004535461A5 (https=) |